This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bates, R. C. Articles by Fisher, D. E. Search for Related Content PubMed PubMed Citation Articles by Bates, R. C. Articles by Fisher, D. E.

A CD44 Survival Pathway Triggers Chemoresistance via Lyn Kinase and Phosphoinositide 3-Kinase/Akt in Colon Carcinoma Cells¹

Cancer Research Unit, Faculty of Medicine, The University of Newcastle, New South Wales 2308, Australia [R. C. B., G. F. B.], and Division of Pediatric Oncology, Dana Farber Cancer Institute and Childrens Hospital, Harvard Medical School, Boston, Massachusetts 02115 [R. C. B., N. S. E., D. E. F.]

A major obstacle to successful treatment of colorectal cancer is chemotherapy resistance. Enhanced expression of variant CD44 isoforms has been associated with aggressive tumor behavior, prompting the question of whether signaling from this receptor might modulate drug sensitivity. Activation of variant CD44 in colon carcinoma cell lines triggered resistance to the drug 1,3-bis(2-chloroethyl)-1-nitrosurea. Resistance was induced by monoclonal antibodies directed against epitopes independent of the hyaluronate-binding region but was not triggered by identical treatment of a carcinoma line expressing the standard CD44 isoform. We observed that variant CD44 produced activation of the src-family tyrosine kinase lyn. Moreover, overexpression of dominant-active lyn recapitulated chemoresistance via a pathway shown to involve activation of phosphoinositide 3-kinase and Akt. These results establish a novel role for CD44 in determining survival of colon carcinoma cells through lyn kinase and Akt. The ability to suppress apoptosis might play a critical role in the onset and development of colorectal malignancies.

This article has been cited by other articles:

				M. Sheffer, M. D. Bacolod, O. Zuk, S. F. Giardina, H. Pincas, F. Barany, P. B. Paty, W. L. Gerald, D. A. Notterman, and E. Domany Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer PNAS, April 28, 2009; 106(17): 7131 - 7136. [Abstract] [Full Text] [PDF]

				D. Garcia-Crespo, E. Knock, N. Jabado, and R. Rozen Intestinal Neoplasia Induced by Low Dietary Folate Is Associated with Altered Tumor Expression Profiles and Decreased Apoptosis in Mouse Normal Intestine J. Nutr., March 1, 2009; 139(3): 488 - 494. [Abstract] [Full Text] [PDF]

				P. Klingbeil, R. Marhaba, T. Jung, R. Kirmse, T. Ludwig, and M. Zoller CD44 Variant Isoforms Promote Metastasis Formation by a Tumor Cell-Matrix Cross-talk That Supports Adhesion and Apoptosis Resistance Mol. Cancer Res., February 1, 2009; 7(2): 168 - 179. [Abstract] [Full Text] [PDF]

				N. K. Williams, I. S. Lucet, S. P. Klinken, E. Ingley, and J. Rossjohn Crystal Structures of the Lyn Protein Tyrosine Kinase Domain in Its Apo- and Inhibitor-bound State J. Biol. Chem., January 2, 2009; 284(1): 284 - 291. [Abstract] [Full Text] [PDF]

				D. A. Chudakova, Y. H. Zeidan, B. W. Wheeler, J. Yu, S. A. Novgorodov, M. S. Kindy, Y. A. Hannun, and T. I. Gudz Integrin-associated Lyn Kinase Promotes Cell Survival by Suppressing Acid Sphingomyelinase Activity J. Biol. Chem., October 24, 2008; 283(43): 28806 - 28816. [Abstract] [Full Text] [PDF]

				H. Guan, Z. Zhou, G. E. Gallick, S.-F. Jia, J. Morales, A. K. Sood, S. J. Corey, and E. S. Kleinerman Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma Mol. Cancer Ther., July 1, 2008; 7(7): 1807 - 1816. [Abstract] [Full Text] [PDF]

				J. Zeilstra, S. P.J. Joosten, M. Dokter, E. Verwiel, M. Spaargaren, and S. T. Pals Deletion of the WNT Target and Cancer Stem Cell Marker CD44 in Apc(Min/+) Mice Attenuates Intestinal Tumorigenesis Cancer Res., May 15, 2008; 68(10): 3655 - 3661. [Abstract] [Full Text] [PDF]

				J M W Gee, V E Shaw, S E Hiscox, R A McClelland, N K Rushmere, and R I Nicholson Deciphering antihormone-induced compensatory mechanisms in breast cancer and their therapeutic implications Endocr. Relat. Cancer, December 1, 2006; 13(Supplement_1): S77 - S88. [Abstract] [Full Text] [PDF]

				S. J. Wang and L. Y. W. Bourguignon Hyaluronan and the Interaction Between CD44 and Epidermal Growth Factor Receptor in Oncogenic Signaling and Chemotherapy Resistance in Head and Neck Cancer. Arch Otolaryngol Head Neck Surg, July 1, 2006; 132(7): 771 - 778. [Abstract] [Full Text] [PDF]

				Q.-s. Zhu, L. Xia, G. B. Mills, C. A. Lowell, I. P. Touw, and S. J. Corey G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth Blood, March 1, 2006; 107(5): 1847 - 1856. [Abstract] [Full Text] [PDF]

				A. Ostapkowicz, K. Inai, L. Smith, S. Kreda, and J. Spychala Lipid rafts remodeling in estrogen receptor-negative breast cancer is reversed by histone deacetylase inhibitor. Mol. Cancer Ther., February 1, 2006; 5(2): 238 - 245. [Abstract] [Full Text] [PDF]

				S. J. Wang and L. Y. W. Bourguignon Hyaluronan-CD44 Promotes Phospholipase C-Mediated Ca2+ Signaling and Cisplatin Resistance in Head and Neck Cancer Arch Otolaryngol Head Neck Surg, January 1, 2006; 132(1): 19 - 24. [Abstract] [Full Text] [PDF]

				O. Prakash, O. R. Swamy, X. Peng, Z.-Y. Tang, L. Li, J. E. Larson, J. C. Cohen, J. Gill, G. Farr, S. Wang, et al. Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis Blood, May 15, 2005; 105(10): 3987 - 3994. [Abstract] [Full Text] [PDF]

				R. S. Hauptschein, K. E. Sloan, C. Torella, R. Moezzifard, M. Giel-Moloney, C. Zehetmeier, C. Unger, L. L. Ilag, and D. G. Jay Functional Proteomic Screen Identifies a Modulating Role for CD44 in Death Receptor-Mediated Apoptosis Cancer Res., March 1, 2005; 65(5): 1887 - 1896. [Abstract] [Full Text] [PDF]

				L. A. deGraffenried, L. Fulcher, W. E. Friedrichs, V. Grunwald, R. B. Ray, and M. Hidalgo Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway Ann. Onc., October 1, 2004; 15(10): 1510 - 1516. [Abstract] [Full Text] [PDF]

				Y. Dai, M. Rahmani, S. J. Corey, P. Dent, and S. Grant A Bcr/Abl-independent, Lyn-dependent Form of Imatinib Mesylate (STI-571) Resistance Is Associated with Altered Expression of Bcl-2 J. Biol. Chem., August 13, 2004; 279(33): 34227 - 34239. [Abstract] [Full Text] [PDF]

				G.-i. Kusakai, A. Suzuki, T. Ogura, S.'i. Miyamoto, A. Ochiai, M. Kaminishi, and H. Esumi ARK5 Expression in Colorectal Cancer and Its Implications for Tumor Progression Am. J. Pathol., March 1, 2004; 164(3): 987 - 995. [Abstract] [Full Text] [PDF]

				M. Goldenberg-Furmanov, I. Stein, E. Pikarsky, H. Rubin, S. Kasem, M. Wygoda, I. Weinstein, H. Reuveni, and S. A. Ben-Sasson Lyn Is a Target Gene for Prostate Cancer: Sequence-Based Inhibition Induces Regression of Human Tumor Xenografts Cancer Res., February 1, 2004; 64(3): 1058 - 1066. [Abstract] [Full Text] [PDF]

				R. F. Thorne, J. W. Legg, and C. M. Isacke The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events J. Cell Sci., January 22, 2004; 117(3): 373 - 380. [Abstract] [Full Text] [PDF]

				L. Y. W. Bourguignon, P. A. Singleton, H. Zhu, and F. Diedrich Hyaluronan-mediated CD44 Interaction with RhoGEF and Rho Kinase Promotes Grb2-associated Binder-1 Phosphorylation and Phosphatidylinositol 3-Kinase Signaling Leading to Cytokine (Macrophage-Colony Stimulating Factor) Production and Breast Tumor Progression J. Biol. Chem., August 8, 2003; 278(32): 29420 - 29434. [Abstract] [Full Text] [PDF]

				V. M. Golubovskaya, S. Gross, A. S. Kaur, R. I. Wilson, L.-H. Xu, X. H. Yang, and W. G. Cance Simultaneous Inhibition of Focal Adhesion Kinase and Src Enhances Detachment and Apoptosis in Colon Cancer Cell Lines Mol. Cancer Res., August 1, 2003; 1(10): 755 - 764. [Abstract] [Full Text] [PDF]

				T. Katakai, T. Hara, M. Sugai, H. Gonda, Y. Nambu, E. Matsuda, Y. Agata, and A. Shimizu Chemokine-independent Preference for T-helper-1 Cells in Transendothelial Migration J. Biol. Chem., December 20, 2002; 277(52): 50948 - 50958. [Abstract] [Full Text] [PDF]